Published in Clin Diagn Lab Immunol on July 01, 1995
PB1-F2 Protein Does Not Impact the Virulence of Triple-Reassortant H3N2 Swine Influenza Virus in Pigs but Alters Pathogenicity and Transmission in Turkeys. J Virol (2015) 0.79
Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection. Clin Diagn Lab Immunol (2005) 0.79
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15
The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol (1987) 6.94
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med (1986) 5.11
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Interleukin 1: an immunological perspective. Annu Rev Immunol (1985) 4.09
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest (1994) 3.12
IL-12: initiation cytokine for cell-mediated immunity. Science (1993) 2.97
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35
Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations. Virology (1974) 2.19
Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol (1987) 1.71
Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature (1989) 1.67
Influenza virus infections and immunity: a review of human and animal models. Lab Anim Sci (1992) 1.65
Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med (1991) 1.55
Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect. Virology (1993) 1.50
IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol (1994) 1.46
Influenza: pathogenesis and host defense. Semin Respir Infect (1992) 1.27
Intracellular hemolysin-producing Listeria monocytogenes strains inhibit macrophage-mediated antigen processing. Infect Immun (1990) 1.00
Shared idiotopes among monoclonal antibodies specific for A/PR/8/34 (H1N1) and X-31(H3N2) influenza viruses. Proc Natl Acad Sci U S A (1984) 1.00
Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas. J Immunol Methods (1990) 0.93
Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol (1993) 0.92
Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. Pathobiology (1991) 0.90
Quantitation of the binding, uptake, and degradation of fluoresceinylated neoglycoproteins by flow cytometry. Cytometry (1987) 0.89
Reduced binding activity of transcription factor NF-kappa B accounts for MHC class I repression in adenovirus type 12 E 1-transformed cells. Cell Immunol (1992) 0.89
Virus infection blocks the processing and presentation of exogenous antigen with the major histocompatibility complex class II molecules. Eur J Immunol (1992) 0.87
Replication of influenza A viruses in an avian macrophage cell line. J Gen Virol (1991) 0.84
Progressive impairment of monocytic function in HIV-1-infected human macrophage hybridomas. AIDS Res Hum Retroviruses (1993) 0.84
Impairment of monocytic function during Trypanosoma cruzi infection. Clin Diagn Lab Immunol (1994) 0.83
Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus. J Virol (1992) 0.83
Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus. J Virol (1992) 0.83
Unique features of influenza viruses, and their implications. Semin Respir Infect (1992) 0.81
Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins. J Exp Med (1991) 0.79
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol (1993) 4.55
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell (2000) 3.65
A genetic linkage map for cattle. Genetics (1994) 3.64
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Immunophysiology of experimental food allergy. Mucosal Immunol (2008) 2.76
Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows. Nature (2010) 2.71
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA (1987) 2.47
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04
Setting the record straight. Tex Med (1998) 2.03
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med (2009) 1.97
Out of the shadows. Tex Med (1998) 1.91
Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol (1992) 1.88
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol (1997) 1.80
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol (1993) 1.70
Liver cells. Methods Enzymol (1979) 1.67
Recipient vessels in head and neck microsurgery: radiation effect and vessel access. Plast Reconstr Surg (1993) 1.66
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
Hormonal control of rat liver regeneration. Gastroenterology (1979) 1.64
Dark matter search results from the CDMS II experiment. Science (2010) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Human malignant T cells capable of inducing an immunoglobulin class switch. J Exp Med (1985) 1.56
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients. Ann Oncol (2005) 1.51
Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. Eur Respir J (2009) 1.51
The chemical composition of wheat and rye and of flours derived therefrom. Biochem J (1945) 1.50
Esophageal foreign bodies in children. 15-year review of 484 cases. Ann Otol Rhinol Laryngol (1991) 1.48
Fit to fight. The unexpected appeal of military medicine. Tex Med (1995) 1.39
Swapping for life. Tex Med (1999) 1.39
Stamp of approval? Board certification becomes managed care criteria. Tex Med (1995) 1.39
CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol (2009) 1.39
It is 25,000 operations and counting for Dr. Howard Gimbel. CMAJ (1989) 1.38
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev (2003) 1.38
Growth state-dependent phenotypes of adult hepatocytes in primary monolayer culture. Proc Natl Acad Sci U S A (1978) 1.36
Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology (1992) 1.34
CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med (1993) 1.31
Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc Natl Acad Sci U S A (1989) 1.30
The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol (1998) 1.29
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis (1997) 1.25
Procarcinogen activation and hormonal control of cell proliferation in differentiated primary adult rat liver cell cultures. Nature (1977) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest (1984) 1.23
Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr (1995) 1.23
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther (1996) 1.21
In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
FURTHER STUDIES IN OSTEOGENESIS. Ann Surg (1919) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS (2001) 1.19
Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses (1993) 1.17
A rapid and efficient immunization protocol for production of monoclonal antibodies reactive with autoantigens. J Immunol Methods (1985) 1.17
T-cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology (1993) 1.16
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol (2001) 1.16
Synaptic distribution of the AMPA-GluR2 subunit and its colocalization with calcium-binding proteins in rat cerebral cortex: an immunohistochemical study using a GluR2-specific monoclonal antibody. Exp Neurol (1996) 1.14
Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol (1991) 1.14
Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J Exp Med (1994) 1.14
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Science (1984) 1.14
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med (1989) 1.13
Glycation impairs high-density lipoprotein function. Diabetologia (2000) 1.12
Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J Immunol (1997) 1.12
Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng (1999) 1.12
Transoral decompression for myelopathy caused by rheumatoid arithritis of the cervical spine. Case report. J Neurosurg (1972) 1.10
Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol (1989) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Genetic determinants of microbial resistance to antibiotics. Rev Infect Dis (1989) 1.09
Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy (2008) 1.09
Antigen trafficking and accessory cell function in respiratory epithelial cells. Am J Respir Cell Mol Biol (1999) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol (1996) 1.06
Towards achieving the Health of the Nation target for cervical cancer: accuracy of cancer registration. J Public Health Med (1994) 1.06
Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin Exp Immunol (1995) 1.06
Preparation of monoclonal antibodies to murine platelet glycoprotein IIb/IIIa (alphaIIbbeta3) and other proteins from hamster-mouse interspecies hybridomas. Biochem Biophys Res Commun (1999) 1.05
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res (1993) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Interleukins 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology (1990) 1.04
Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol (1993) 1.04
Selective RNA editing and subunit assembly of native glutamate receptors. Neuron (1994) 1.03
The anti-HIV-1 activity of chloroquine. J Clin Virol (2001) 1.03
Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists. J Med Chem (1996) 1.03
Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin Ther (1997) 1.03
Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer. J Clin Oncol (1999) 1.02
PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. Nat Med (1999) 1.02
Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56lck. J Exp Med (1995) 1.02
Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest (1997) 1.02
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol (2014) 1.01
Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7. J Neurosci (1993) 1.01
The role of epithelial cells in immune regulation in the gut. Semin Immunol (2001) 1.01
CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood (1990) 1.00